Company profile for Akers Biosciences

NEW Drugs in Dev: 2
PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Akers Biosciences mission is dedicated to solving global health challenges. Akers was founded in 1989 and has over 30 years of success in the health diagnostic industry having developed proprietary, in vitro diagnostic technologies. In March of 2020, in an attempt to further their mission, Akers announced a strategic partnership with Premas Biotech. The partnerships primary objective is to focus on novel vaccine candidates....
Akers Biosciences mission is dedicated to solving global health challenges. Akers was founded in 1989 and has over 30 years of success in the health diagnostic industry having developed proprietary, in vitro diagnostic technologies. In March of 2020, in an attempt to further their mission, Akers announced a strategic partnership with Premas Biotech. The partnerships primary objective is to focus on novel vaccine candidates. The emergence of this pandemic offers an opportunity for the company to be a solution in the healthcare space, one that sets the stage for our next chapter of growth.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
201 Grove Road West Deptford, NJ 08086
Telephone
Telephone
+1 (856) 848-8698
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20210416005432/en

BUSINESSWIRE
16 Apr 2021

https://www.businesswire.com/news/home/20210416005432/en/Akers-Biosciences-and-MyMD-Pharmaceuticals-Announce-Stockholder-Approval-of-Merger#:~:text=Akers%20Biosciences%20and%20MyMD%20Pharmaceuticals%20Announce%20Stockholder%20Approval%20of%20Merger,-Shares%20to%20commence&text=BALTIMORE%2D%2D(BUSINESS%20WIRE)%2D%2DAkers%20Biosciences%2C%20Inc.&text=Upon%20closing%2C%20the%20combined%20company%20will%20be%20named%20MyMD%20Pharmaceuticals,%E2%80%9D%20beginning%20April%2019%2C%202021.

BUSINESSWIRE
16 Apr 2021

https://www.businesswire.com/news/home/20210413005702/en

BUSINESSWIRE
13 Apr 2021

https://www.businesswire.com/news/home/20210322005123/en

BUSINESSWIRE
22 Mar 2021

https://www.pharmaceutical-technology.com/news/covid-19-temperature-transmission/

PHARMACEUTICAL-TECHNOLOGY
19 Feb 2021

https://www.biospace.com/article/releases/akers-biosciences-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-and-amp-foti-llc-investigates-merger-of-akers-biosciences-inc-aker/?s=79

BIOSPACE
03 Dec 2020

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty